Michael Jacobi - Actelion Member of the Board of Directors

Director

Dr. Michael Jacobi was Member of the Board of Directors of Actelion Ltd since April 24, 2009. He is Chairman of the Finance and Audit Committee of the Company. He was Chief Financial Officer at Ciba Speciality Chemicals Inc. from 1996 until 2007. He joined the Ciba Group in 1978 and subsequently held various executive positions in the financial area in Switzerland, Brazil and the United States. Since 2003, he has served on the Board of Directors of Sonova Holding AG, formerly Phonak AG, since 2004 as the Head of the Audit Committee. Furthermore, he has served on the Board of Directors of Hilti AG since 2007. Since 2008, he has also been Member of the Board of Trustees of the Martin Hilti Family Trust. He received a Ph.D. in Business Administration from Universitaet St. Gallen, Switzerland and continued his studies at the University of Washington, Seattle, USA, and completed a Program for Management Development at Harvard Business School, Boston, USA. since 2009.
Age 63
Tenure 15 years
Professional MarksPh.D
Phone41 61 565 65 65
Webhttp://www.actelion.com

Actelion Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated a profit of $23.87 on every $100 spent on assets. This is very large. Similarly, it shows a return on equity (ROE) of 47.08 %, meaning that it generated $47.08 on every $100 dollars invested by stockholders. Actelion's management efficiency ratios could be used to measure how well Actelion manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Lilian TomovichDine Brands Global
53
Howard BerkDine Brands Global
56
Lee FosterWestinghouse Air Brake
74
Maria JaumeMeli Hotels International
N/A
Robert BrooksWestinghouse Air Brake
73
Fernando SilvaMeli Hotels International
N/A
Alfredo BodmerMeli Hotels International
N/A
Mark McEachenBJs Restaurants
47
Douglas PasqualeDine Brands Global
66
Wesley NicholsBJs Restaurants
51
Patrick RoseDine Brands Global
73
Gary ValadeWestinghouse Air Brake
72
Caroline NahasDine Brands Global
72
Brian HehirWestinghouse Air Brake
67
Carina LazaroMeli Hotels International
N/A
James PozzoBJs Restaurants
59
Juan CerdaMeli Hotels International
N/A
Rana SchirmerBJs Restaurants
N/A
Roderick McGeochCorporacion America Airports
67
David ArendtCorporacion America Airports
67
Luis TerminelMeli Hotels International
71
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes low molecular weight drugs for unmet medical needs. The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Actelion Ltd is traded on OTC Market in USA. Actelion Ltd UNSP [ALIOY] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Actelion UNSP Leadership Team

Elected by the shareholders, the Actelion's board of directors comprises two types of representatives: Actelion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actelion. The board's role is to monitor Actelion's management team and ensure that shareholders' interests are well served. Actelion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actelion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rudi Frank, Senior Vice President Head Global Quality Management, Member of the Extended Executive Committee
Marian Borovsky, Senior Vice President Group General Counsel, Member of the Extended Executive Committee, Corporate Secretary to the Board of Directors
Thomas Widman, Co-Founder
Nicholas Franco, Executive Vice President Chief Business Development Officer, Member of the Executive Committee
Christian Albrich, Senior Vice President Head Global Human Resources and a member of the Extended Actelion Executive Committee
Martine Clozel, Senior Vice President Chief Scientific Officer, Head of Drug Discovery, Pharmacology & Preclinical Development, Member of the Extended Executive Committee
Robert Bertolini, Member of the Board of Directors
Juhani Anttila, Member of the Board of Directors
JeanPierre Garnier, Chairman of the Board of Directors
David Stout, Member of the Board of Directors
JeanPaul Clozel, CEO, Member of the Executive Committee, Delegate of the Board of Directors
Guy Braunstein, Executive Vice President Head of Global Clinical Development, Member of the Executive Committee
Herna Verhagen, Member of the Board of Directors
Andrew Weiss, Senior Vice President Head Investor Relations and Corporate Communications, Member of the Extended Executive Committee
Michael Jacobi, Member of the Board of Directors
Jean Malo, Member of the Board of Directors
Otto Schwarz, COO, Executive Vice President Member of the Executive Committee
Andre Muller, CFO, Executive Vice President Member of the Executive Committee
Peter Gruss, Member of the Board of Directors
John Greisch, Member of the Board of Directors

Actelion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Actelion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Actelion in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Actelion's short interest history, or implied volatility extrapolated from Actelion options trading.

Pair Trading with Actelion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Actelion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actelion will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Illinois Tool could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illinois Tool when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illinois Tool - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illinois Tool Works to buy it.
The correlation of Illinois Tool is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illinois Tool moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illinois Tool Works moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illinois Tool can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Actelion Pink Sheet

If you are still planning to invest in Actelion UNSP check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Actelion's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences